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Abstract 
Wound infections in AIDS patients increase discomfort, prolong hospital stay, render an additional burden upon an already 
debilitated patient and weaken the immune system further. Treatment must relate to the aetiology of the wound and take into 
account the patients underlying health problems. The treatment of wounds in HIV-AIDS patients is not different from the 
standard treatment. There are wound -related criteria for selecting the appropriate types of dressing. The best dressing for 
postoperative wound healing by secondary intention is unknown. Continuing wound evaluation and the appraisal of what 
dressing is useful for the type of wound and stage of healing is the basis of optimum wound care Optimum wound care, 
emotional support; health education will enhance both the emotional and physical wellbeing of the HIV-AIDS patient. 
Key words: Human immunodeficiency virus (HIV), Acquired immune deficiency syndrome (AIDS), wound infection, 
delayed wound healing, optimum wound care, dressing types, nutrition, and pain control  
INTRODUCTION 
Acquired immune deficiency syndrome (AIDS) is 
becoming an increasing problem to the general 
surgeon (1, 2, 3). It is caused by infection with the 
Human Immunodeficiency Virus (HIV) which is an 
RNA virus that infects predominantly human T 
lymphocytes. It is transmitted by contaminated body 
fluids and, after a variable latent period of up to 2 
years, it produces diminished immunological 
function which is manifest as AIDS. The suppressed 
cellular immunity allows the development of 
malignancies (Kaposi’s sarcoma and lymphoma) and 
opportunistic infections including Pneumocystis carinii 
pneumonia, cryptosporidium, cytomegalovirus 
(CMV), herpes simplex virus (HSV), varicella zoster 
virus (VZV) and fungi (candida) (4). 
AIDS is a worldwide pandemic with the highest 
prevalence in sub-Saharan Africa. Since its discovery 
in 1981, AIDS has rivalled the worst epidemics in 
history. As of 2004 an estimated 25 million people 
have died, and 40 million are living with HIV. There 
are about 58000 HIV/AIDS patients in the UK. The 
incidence has apparently levelled in the USA and 
Western Europe and the mortality from these 
infections has decreased as highly active antiretroviral 
therapy (HAART) has become widely available (4, 5, 
6, 7). 
HIV-AIDS patients being immunosuppressed will 
suffer from wound healing impairment and an 
increased susceptibility to wound infection. It appears 
that patients who are HIV positive without AIDS 
have no increased risk of wound problems, while 
those with AIDS are more likely to have delayed 
wound healing (5, 6). Surgery should be offered to 
HIV- positive patients without AIDS based on 
standard indications just as for HIV negative patients, 
but AIDS patients with more advanced disease, low 
CD4 counts (< 100) or poor performance status are at 
an increased risk for poor wound healing (5).  
 
Although surgical procedures can be safe and 
effective therapeutic modalities, the benefits of 
resolution of symptoms must be balanced against this 
risk. Aggressive surgical interventions must be 
undertaken with caution (7, 8). The consequences of 
wound infection in AIDS patients are grave. They 
increase discomfort, prolong hospital stay, render an 
additional burden upon an already debilitated patient 
and weaken the immune system further.  
A trial into ‘task-shifting’ from doctors to nurses in 
the management of HIV- infected patients receiving 
antiretroviral therapy has proved a success (9). It also 
would seem to be true with their wound care, as 
wound care has always been the main domain in 
surgical nursing, facilitated by the closer nurse-
patient relationship.  
 
Wound care  
Wound healing is a complex but highly integrated 
process that involves several cell types. The ultimate 




continuity and a rapid return to normal function (10). 
Wound healing has three phases; a lag phase of 2-3 
days which is the acute inflammatory response to 
injury; an incremental phase which involves the 
progressive collagen synthesis by fibroblasts and gain 
in tensile strength; and a plateau (remodelling) phase 
in which excessive collagen is removed with decrease 
in fibroblasts and inflammatory cells (11). The first 7- 
10 days is usually sufficient to allow removal of skin 
sutures without wound disruption (10). 
Factors that adversely affect healing need to be 
common knowledge to surgeons so that where 
possible they can be eliminated to enhance patient 
recovery and the cost-effectiveness of care. The 
characteristics required of a wound for rapid and 
sound healing are ; no (or minimal) foreign material, 
no infection, accurate apposition, no excess tension, 
good blood supply and no haematoma separating 
edges (12). In a heavily contaminated or infected 
wound it may be appropriate to use delayed primary 
closure or allow healing to proceed by second 
intention (13). 
The World Health Organization suggestions for 
reduction of wound infection (14, 15) are as follows : 
1) short preoperative stay to prevent acquisition of 
hospital acquired infection, 2) antiseptic shower 
before operation, 3) shaving kept to a minimum, 4) 
avoid wound contamination, 5) meticulous attention 
to surgical technique, and 6) as speedy an operation 
as it is safe. Wound care for HIV-AIDS patients 
should incorporate these suggestions although recent 
trials have shown no clinical benefit of antiseptic 
showering before operation in normal patients (16, 
17).  
 
Sources of infection in HIV-AIDS patients  
The sources of infection are a) endogenous and b) 
exogenous (18). Endogenous infections arise from the 
patient’s normal bacterial flora which contaminate the 
wound and cause infection. Prevention is by 
scrupulous patient hygiene, using clean bed linen and 
clothing, and avoiding wound contamination by poor 
dressing technique (15, 19). Exogenous infections 
arises from cross infection through hospital staff 
(hands), other patients, equipment and the 
environment (e.g. dust on curtain rails, bed 
frames).1Prevention is by washing hands using liquid 
soap and drying carefully after every patient contact. 
It is advisable to use a bactericidal agent prior to 
aseptic procedures including wound dressing. An 
alternative is alcoholic hand rub especially at the 
bedside. Infection control also includes the use of 
sterile gloves, forceps and hand washing after 
removal of gloves (14, 20). The principles of wound 
care in AIDS patients are little different from the 
standard treatments (1, 2, 6, 7).  
 
Principles of wound care: 
 1. Aseptic technique ; the use of sterilised instruments 
with disinfected hands in sterilsed gloves working on 
an antiseptically disinfected wound and surrounding 
skin covered with sterilised drapes. Antiseptically 
prepared skin eliminates exogenous skin organisms 
which are an important source of post operative 
wound infection (21). 
2. The type of wound will determine the approach. Is it 
surgical or non-surgical? If surgical, is it a clean 
wound? e.g. hernia repair; clean-contaminated? e.g. 
cholecystectomy; contaminated wound? e.g. colonic 
resection, or a dirty wound? e.g. peritonitis secondary 
to intestinal/abscess perforation. Is the wound 
superficial or deep? Non-surgical wounds may be 
traumatic laceration, degloving, pretibial injuries or 
burn injuries. All non-surgical wounds should be 
regarded as potentially contaminated (22, 23). 
 3. The choice of dressing depends on individual wound 
evaluation. Is it necrotic, sloughy, infected, and 
granulating or epitheliazing? Is it flat or a cavity? 
Ideally the wound should be kept warm and moist, 
protected from infection and physical damage. 
Excessive moisture in the wound bed may soften and 
weaken the wound edges (maceration). As a result 
the wound may enlarge and pathogenic organisms 
will be able to penetrate the surrounding skin and 
cause infection (24). Exudates and dead tissue should 
be removed following copious saline irrigation 
especially of dirty wounds. 
 4. Continuing evaluation of the wound is essential to 
detect early tissue degeneration which will suggest a 
change in dressing, cleanser or debrider. Evaluating 
the old dressing is helpful (25,26). Good blood supply 
to the wound may be promoted by refreshening the 
wound and healthy tissue maintained in and around 
the wound. 
 5. Wound sutures should be given careful 
consideration. As wound healing may be delayed, 
each individual suture line must be evaluated to 
establish if healing is complete (10). The timing of 
suture removal should not depend on dogma. It 
should follow the evaluation of the individual’s 
wound as there are various factors, especially the site 
and the patient’s general health including immune 
status which may delay healing. The loose sutures 
used to close the upper or lower eyelid wounds are 
often removed at 48 h. Elsewhere on the face, sutures 
are removed at between 4 and 5 days all because of 
their excellent blood supply. Where movement 
increases the risk of dehiscence, in hand and limb 
wounds for example, it is common to leave in sutures 
for 10 days. Sutures left in longer than necessary may 
encourage infection, and will leave unnecessary 
marks or keloids especially on negroid skin. 
 6. Wound drainage: closed suction drainage minimises 
the risk of wound infection. The drain should be 
removed as soon as the fluid ceases (17, 18). 
 
Wound assessment  
This has had a tendency to be broad, subjective, 
inadequate and providing inaccurate information. 
The practitioner should appreciate the stage of 
healing, the type of tissue and expectation of time to 
complete healing. The choice of dressing is commonly 
based on the type of tissue present or as a colour 
scheme, e.g. black, yellow, red, and pink. There are 
dangers with this type of classification, as ‘black’ 




gangrene, which would affect the treatment chosen. 
Also ‘yellow’ could be slough but also fat, tendon or 
bone. Sloughy wounds comprise a complex mixture 
of fibrin, protein, serous exudate, leucocytes and 
bacteria. Granulating wounds comprise of collagen 
and proteoglycans which produce a gel- like matrix. 
Epitheliazing wounds consist of soft and fragile tissue 
and can be easily damaged by inappropriate dressing 
choice. Without such knowledge dressing selection is 
likely to be arbitrary, and potentially ineffective and 
wasteful of both time and resources (25,26). 
Continuing wound evaluation and the appraisal of 
what dressing is useful for the type of wound and 
stage of healing is the basis of optimum wound care 
(26). The difficult task facing the practitioner is to 
identify the most appropriate dressing for each stage 
of the healing process as no single wound dressing 
will be able to deal with all wound situations. There 
are, however, wound-related criteria for selecting the 
appropriate types of dressing. 
 Thomas and Leigh (25) described the optimum 
healing environment for the wound, which should be: 
moist with exudates but not macerated; free of clinical 
infection and excessive slough; free of toxic chemicals, 
particles or fibres released by the dressing; at the 
optimum temperature; undisturbed by frequent or 
unnecessary dressing changes and at the correct pH. 
Research in this area continues in attempting to 
identify how this optimum environment can be 
achieved (24, 26). There are several reasons for using 
a dressing: 1) to protect from drying, infection, 
further damage, 2) to debride- mechanically, 
chemically and to promote autolysis (27). 3) to 
control- bleeding ,exudate, pain, odour, 4) to 
maximize compliance- patient, nurse, doctor system. 
The patient should be able to continue with her 
normal daily routine and the dressing regime should 
reflect this. 5) to stimulate healing — 
pharmacologically, physically (12, 28, 29). Dressings 
need to be changed less often for a clean wound but 
there is no substitute for frequent dressing changes in 
a grossly contaminated or recently debrided infected 
wound. Wounds should be kept moist (but not wet) 
at all times for normal cellular physiology. Desiccated 
tissue is dead tissue and must be sharply debrided. 
 Factors that are important in promoting healing 
include debridement, promotion of granulation and 
promotion of epithelialization. These factors can then 
be compared with the properties of the various 
dressings’ materials available. If a number of 
dressings satisfy the wound’s needs, the final choice 
is made by considering relative efficacy, cost, 
convenience and patient acceptability. There are a 
number of factors which influence the process of 
selecting the most appropriate dressing. These 
include the individual patient, the wound, and the 
type of dressing.   
 
Dressing types  
Modem wound management offer a whole host of 
materials and dressings that provides a variety of 
benefits in the process of wound healing (30). A range 
of modern dressings might consist of contact 
materials: gauze (not as first option, if at all), low! non 
—adherent dressings; semi- permeable films; 
hydrogels; hydrocolloids; alginates; foams; 
antimicrobials plus growth factors. The best dressing 
for postoperative wounds healing by secondary 
intention is unknown because of the small, poor 
quality trials existing which render the evidence for 
best dressing insufficient (30). Foam is best studied as 
an alternative to gauze and appears to be preferable 
in terms of pain reduction, patient satisfaction and 
nursing time (31, 32). The traditional dressings 
include gauze and ‘Gamgee’, which are cheap but 
which have a tendency to stick to wounds causing 
trauma and pain on removal. Low adherent and non- 
adherent dressings provide a surface which is less 
traumatic to remove. Tulle dressings, if used correctly 
can be of low adherence. They are also cheap but their 
use is limited on wounds with high or viscous 
exudates. 
 Semi permeable film dressings are made from a clear 
polyurethrane film coated with an adhesive. They 
conform well, are resistant to shearing and tearing, 
and permit constant observation. They provide and 
maintain an environment conducive to healing. Such 
dressings are not suitable in the case of heavily 
exuding wounds (33, 34, 35). The main advantages of 
using a semi permeable film are: acts as a bacterial 
barrier, elastic and durable, permeable to water and 
gases. The main disadvantages are: tends to collect 
fluid, which can cause maceration, some are difficult 
to apply correctly, can only be use for a flat surface, 
and skin reactions can be caused by adhesive. 
Examples are Bioclusive, Cutifilm, Epiview Opsite 
Flexigrid, Tegaderm.  
 
Hydrocolloids e.g. granuflex consist of a mixture of 
carboxylmethylcellulose, pectins, gelatins and 
elastomers. They are available in pastes, granules and 
wafers. On contact with wound secretions, the 
hydrocolloid material forms a gel, providing the 
optimum conditions for moist wound healing (34). 
Patients and users should be warned that the gel 
becomes pus- like in appearance and they should 
expect to detect an odour. The correct size of dressing 
may be left in place for 5-7 days. The main 
advantages of using hydrocolloid dressings are: easy 
to use, durable, positive effect on healing and cost-
effective. The main disadvantages are: they can cause 
an odour, sometimes difficult to remove, cannot be 
used for cavities and may cause over- granulation.  
Hydrofibre consists of sodium 
carboxymethylcellulose spun into a fibre. It is highly 
absorbent and retains exudates. The fibres ‘gel’ into a 
sheet. The dressing is indicated for moderate to 
highly exuding wounds. It can be used for infected 
wounds, as long as it’s changed daily. The main 
advantages are: they are comfortable, do not cause 
maceration of surrounding skin highly absorbent and 
can be used on sloughy wounds (33, 24). Its main 
disadvantages are: some forms are costly and 




 Hydrogels e.g. intrasite gel consist of insoluble 
polymers, water and propylene glycol. They interact 
with fluid and absorb and retain large volumes of 
exudates (36). These dressings are available in 
different forms- sheets or gels. They are effective 
debriding/ desloughing agents and may be applied 
throughout the healing cycle (27).  A hydrogel 
dressing is used on necrotic tissue because it 
facilitates autolytic debridement of rehydrating dead 
tissue and promotes phagocytic and enzymatic 
activity. Their use in the acute surgical cavity wound 
is not yet reported and maceration can occur in 
wounds that are heavily exuding. Their main 
advantages are: comfort, absorbent and debriding 
properties and as potential carriers for other 
treatments. Their main disadvantages include the 
requirement for frequent changing, can cause 
maceration of surrounding tissue, some forms are 
costly, and difficulty to retain on wound because of 
relative liquidity.  
Alginate dressings e.g. Sorbsan, Kaltostat occur 
naturally as mixed salts of alginic acid and are found 
in and extracted from certain species of seaweed. 
When used on moderately or heavily exuding 
wounds, alginates will absorb secretions to form a gel, 
and this gel provides the opimum humidity and 
temperature conditions for moist wound healing (34). 
They are available in sheet form, packing/ribbon and 
as extra-absorbent sheets. Gentle irrigation with 
normal saline is effective in removing the dressing. 
Their main advantages are: varying absorbencies, 
forms a gel which is easily removed, can be used to 
pack sinuses and some have haemostatic properties. 
The main disadvantages are not to be used on dry 
wounds; sometimes require a quantity of saline to 
remove and require frequent changing if wet.  
Foam dressings consist of polyurethane or silicone 
foam. They are absorbent (negative pressure wound 
dressings) and retain a moist environment (31). They 
are suitable for a wide range of granulating wounds, 
both flat and cavity. Wound healing for even chronic 
wounds can be greatly increased (30). Great prudence 
should be used; apply negative pressure wound 
dressing only when indicated. They are currently two 
types of cavity foam dressings: 1) liquid foam 
polymer- comes in two parts, a base and a catalyst, 
which are mixed directly to form a setting mixture. 
This sets to form a soft, spongy stent of the cavity. 2) 
Hydrocellular cavity wound dressing is available in a 
range of preformed sizes. Advantages of using foam 
dressings are: thermal insulation, protection (prevents 
‘strike through’ of exudate to wound surface), 
permeable to water/gases, easily shaped and varying 
degrees of absorbency. The disadvantages are; costly 
and not always available. Examples are Allevyn, 
Flexipore, Lyofoam, Spyrosorb and cavicare.  
 
Figure 1: Foam (Allevyn) dressing of a granulating laparotomy wound  
 
Antimicrobials:  
Aseptic techniques help decrease the risk of infection 
as does the use of antibiotics in wounds that are 
contaminated (21). The use of topical agents has been 
challenged in the last decade, which has led to a 
decline in their usage. Antiseptics can be toxic when 
used on open wounds and disinfectants including 
hypochlorite solution such as Dakin’s solution, 
Edinburgh universal solution (Eusol) are also toxic to 
healing tissues but have anecdotally found a role in 
debridement and in wound bed preparation prior to 
skin grafting,. However, given the problems 
surrounding the overuse of systemic antibiotics (rise 
in resistant organisms notably MRSA and emergent 
infections such as Clostridium difficile), many clinicians 
are now reviewing the clinical and experimental 
evidence against antiseptics with renewed 
enthusiasm (37). All wounds, regardless of type, may 
become colonised by microorganisms. However, the 
presence of bacteria does not necessarily indicate 
infection. It is the species of bacteria present or the 
rapid increase in a number of pathogenic bacteria past 
a certain critical level that leads to a clinical infection 
which is detrimental to wound healing.8 Clinical 
infection may necessitate treatment with systemic 
antibiotics and/or the use of a medicated dressing. 
These dressings include medicated tulles, iodine  
 
(Inadine) and silver- based products (13). In 
neutropenic HIV/AIDS patients with disseminated 
candidiasis, wound swabs of chronic (delayed-
healing) wounds will grow fungi that would respond 
to systemic antifungal medication (38,40). 
 
HIV infected patients are at high risk for community-
acquired MRSA. Monitoring the results of 
antimicrobial sensitivity profiles in their patient 
population will allow the clinician to base the empiric 
antimicrobial therapy upon local resistance patterns. 
Incision and drainage of a cutaneous abscess may be 
required and the wound should be cared for using 
standard wound care techniques. Subsequent follow-
up is necessary to care for the healing wound and to 
assure that the empirical antimicrobial agent being 




antimicrobial sensitivity profile obtained from the 
wound culture (41). 
 The following factors should be considered before 
prescribing an antimicrobial product: local or 
systemic infection; likely infective organism; 
increasing problems of resistance with overuse of 
antibiotics and antimicrobials; sensitivities of the 
patient to products and length of proposed treatment 
(37,39,40). Examples are Sofra-tulle, Fucidin Intertulle, 
Bactigras, Serotulle, Clorhexitulle (contains 
chlorhexidine acetate 0.5 %)- used extensively in 
bums management. Inadine- similar in appearance to 
other tulle products contains povidone iodine in 
polyethylene glycol base on a knitted viscose fabric. 
Silver sulphadiazine (Flamazine)- has a broad 
spectrum antibacterial effect, particularly against 




Growth factors  
Developments in molecular biology have elucidated 
30 biological mediators that are known to have an 
effect on wound healing. They play an important role 
in the normal wound healing process and have the 
potential to be used as a topical treatment for wounds 
to promote healing. In normal intact skin there is 
biochemical evidence of continual cytokine activity 
with a balance between inhibitory and stimulatory 
factors to provide a stable epidermis. In the presence 
of tissue injury, as with an acute wound, the growth 
factor activity increase. The following issues should 
be considered in relation to the use of growth factors: 
the growth factor administered must be appropriate 
to the stage of healing; the wound should actually be 
deficient in the growth factor being applied; the 
growth factor should be delivered in sufficient 
amount and duration to produce the desired 
response. Examples are epidermal growth factor 
(EGF), transforming growth factor (alpha TGF alpha 
and βTGFβ; platelet derived growth factor (PDGF), 
fibroblast growth factor (FGF); and tumour necrosis 
factor (TNF). The disadvantages of using growth 
factors are: cost of treatment, treatment may not be 
available and the application method. It may need to 
be injected into the wound, and the choice of which 
growth factor, when, and what dosage is a problem 
(42). Growth factors are obviously not an alternative 
to good wound care.  
 
Artificial and living skin equivalents  
Topical antimicrobials decrease the rate of 
colonisation of a wound, but do not prevent microbial 
invasion and proliferation. Therefore it is essential to 
close large wounds especially burn wounds by skin 
grafting after early wound excision and removal of 
toxic nonviable tissue. Depending on its composition, 
tissue- engineered skin can facilitate cell proliferation, 
production of extracellular matrix components and 
increase local concentrations of growth factors in the 
wound. Skin substitutes include epidermal 
components, e.g. Vivoderm, dermal components, e.g. 
Dermograft, and composite grafts. i.e. those 
containing epidermal and dermal components, e.g. 
Apligraf. No synthetic dermal replacement has been 




Adequate nutrition aids the ability to cope with 
surgery and decreases the risk of post operative 
infection.. It assists recovery (the body’s response to 
trauma), promote wound healing, immune function 
and avoids complications like deep vein thrombosis 
and pressure sores (45, 46). The assessment of 
nutritional status preoperatively identifies those at 
risk. Wound has high priority when competing with 
unwounded tissue for body resources. Therefore 
malnutrition has to be very severe before healing is 
affected. Wound dehiscence and infection are 
common when the serum albumin is low. When 
recent weight loss is greater than 20% of original 
weight healing problems can be anticipated (47). 
Protein meal and vitamin C (ascorbic acid) should be 
encouraged. The protein, collagen is the basic 
framework of a healed wound. It is synthesised 
within the endoplasmic reticulum of the fibroblasts 
and leaves the cell as tropocollagen. Proline and 
lysine are essential for collagen formation and oxygen 
and ascorbic acid (vitamin C) are necessary for 
proline hydroxylation and incorporation into 
tropocollagen. Tropocollagen polymerises between 
cells to form cross banded collagen fibrils (46, 48). 
Zinc is a component of enzymes involved in the 
healing process. Its deficiency retards healing. 
Supplements of ascorbic acid and zinc are effective 
when these factors are deficient but do not improve 
healing in normal subjects.  Some patients may need 
nasogastric enteral feeding if the gut is functional.   
If insufficient; nutrients should be given as total 
parenteral nutrition (TPN) (48, 49). Over the past 
decade there has been increasing interest in the use of 
specially formulated feeds, both enteral and 
parenteral, to modulate the immune response to 
injury and illness. Although no study has specifically 
examined the role of these feeds in HIV/AIDS 
patients, there is increasing evidence that they may be 
beneficial in the management of malnourished 
surgical and critically unwell patients (48, 50).  
Glutamine is considered to be a ‘conditionally 
essential amino acid; although it is synthesised in 
most tissues, plasma concentrations become depleted 
when consumption is increased, such as in metabolic 
stress and infection. Glutamine acts as both a nitrogen 
and energy source for lymphocytes and small 
intestinal mucosa, and reduced concentrations are 
associated with immune dysfunction and poor 
outcomes (51).  
 
Patient comfort 
 Pain control is essential in reducing complications 
postoperatively. Pain causes a rise in cortisone via the 
hypothalamo-pituitary axis. Cortisone causes 
gluconeogenesis and this delays wound healing as 
protein is depleted. Increased cortisone also dampens 




however should be avoided as they can depress 
respiration and predispose chest infection. For painful 
short procedures for example wound dressing and 
physiotherapy entenox (nitrous oxide gas) may be 
given (3, 52). 
 
Summary  
The treatment of wounds in HIV-AIDS patients is not 
different from the standard treatments. The treatment 
must relate to the aetiology of the wound and take 
into account the patient’s underlying health problems 
(including medical history, medication, nutritional 
status, lifestyle e.g. tobacco and alcohol habits, 
psychological problems and quality of life). Prior to 
selecting the best dressing the characteristics of the 
wound bed such as necrotic tissue, granulation tissue, 
infection; the condition of the surrounding skin ( 
normal, oedematous, white, shiny, warm, red, dry, 
scaling, thin) and the clinical signs of critical 
colonisation or local infection : delayed healing, 
odour, abnormal granulation tissue, increased wound 
pain and excessive exudate , are evaluated. There are 
wound- related criteria for selecting the 
appropropriate types of dressing. An ideal dressing 
should maintain a moist environment for healing, 
enable trauma-free removal, facilitate gaseous 
exchange, impermeable to organisms and free from 
particulate or toxic contaminants.  
However, the best dressing for post operative 
wounds healing by secondary intention is unknown. 
Successful wound management depends on a flexible 
approach to the selection and use of products based 
on the understanding of the healing process and a 
knowledge of the properties of the various dressings 
available. For example the following choices are a 
suitable treatment for removal of necrotic tissue; 
surgical debridement, use of hydrogel dressing, use of 
hydrocolloids, use of an enzymatic agent, and use of 
occlusive dressing. Exposure to air will only serve to 
dry the necrotic tissue more and not allow the moist 
environment needed for cellular activity. Necrotic 
tissue requires either moisture in some form or sharp 
debridement. An infected wound may require 
surgical revision to facilitate free drainage. An 
alginate dressing that facilitates haemostasis and 
absorbs exudate would be appropriate at this stage. 
More traditional dressings such as gauze packing are 
difficult to remove and are extremely painful for the 
patient. Granulating and epitheliazing wounds will 
require protection from further trauma. Dressings 
that are suitable are alginates, foams or hydrocolloids. 
The aim of cavity wound management is to lightly 
pack the cavity to maintain free drainage. Absorption 
of exudate and ease of removal would be the two  
main considerations. Alginate and cavity foam 
dressings are the usual treatment of choice as they are 
easier to use in terms of application. Film dressings 
are indicated for superficial wounds and will not 
absorb exudate. The use of medicated dressings 
should be reserved for wound infection.  
There have been drastically improved surgical 
outcome as compared to the past with the advent of 
HAART, supported by the preventive measures 
against occupational HIV transmision, good 
anaesthetic and preoperative care. The AIDS-related 
surgical emergencies such as gut (Non-Hodgkin’s) 
lymphoma, infective colitis (bacterial CMV) kaposi 
sarcoma have declined. With increasing survival of 
these patients, however, the other non-AIDS related 
elective or emergency surgery predominate and thus 




HIV-AIDS patients should not be discriminated 
against with regard to receiving appropriate surgical 
intervention for fear of wound healing problems. 
Surgical procedures can be safe and effective 
therapeutic modalities. There are minimal problems 
with wound healing if wound care for HIV-AIDS 
patients incorporate the WHO suggestions or the UK 
NICE guidelines for reduction of wound infection. 
Continuing wound evaluation and the appraisal of 
what dressing is useful for the type of wound and 
stage of healing is the basis of optimum wound care 
.Adequate nutrition especially in HIVAIDS patients 
facilitates wound healing and decrease wound 
infection by improving immune function. The 
improved surgical outcomes together with the 
preventive measures against occupational HIV 
transmission have resulted in the treatment of HIV/ 
AIDS patients becoming an accepted part of routine 
surgical practice.  
Minimally invasive surgery is particularly relevant to 
both the HIV/AIDS patient and the surgeon, as in the 
former the adverse effect of wound healing and 
surgical outcome, and in the latter the risks of 
exposure are both minimised. Optimum wound care, 
emotional support, health education will enhance 
both the emotional and physical well-being of the 
HIV-AIDS patients.  
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